Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP
- PMID: 15372104
- PMCID: PMC516260
- DOI: 10.1172/JCI21382
Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP
Abstract
Persistent reduction of renal perfusion pressure induces renovascular hypertension by activating the renin-angiotensin-aldosterone system; however, the sensing mechanism remains elusive. Here we investigated the role of PGI2 in renovascular hypertension in vivo, employing mice lacking the PGI2 receptor (IP-/- mice). In WT mice with a two-kidney, one-clip model of renovascular hypertension, the BP was significantly elevated. The increase in BP in IP-/- mice, however, was significantly lower than that in WT mice. Similarly, the increases in plasma renin activity, renal renin mRNA, and plasma aldosterone in response to renal artery stenosis were all significantly lower in IP-/- mice than in WT mice. All these parameters were measured in mice lacking the four PGE2 receptor subtypes individually, and we found that these mice had similar responses to WT mice. PGI2 is produced by COX-2 and a selective inhibitor of this enzyme, SC-58125, also significantly reduced the increases in plasma renin activity and renin mRNA expression in WT mice with renal artery stenosis, but these effects were absent in IP-/- mice. When the renin-angiotensin-aldosterone system was activated by salt depletion, SC-58125 blunted the response in WT mice but not in IP-/- mice. These results indicate that PGI2 derived from COX-2 plays a critical role in regulating the release of renin and consequently renovascular hypertension in vivo.
Figures






Comment in
-
Prostanoids and blood pressure: which way is up?J Clin Invest. 2004 Sep;114(6):757-9. doi: 10.1172/JCI22929. J Clin Invest. 2004. PMID: 15372097 Free PMC article. Review.
Similar articles
-
Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.J Am Soc Nephrol. 2005 Aug;16(8):2354-62. doi: 10.1681/ASN.2004070556. Epub 2005 Jun 23. J Am Soc Nephrol. 2005. PMID: 15976003
-
Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake.Am J Physiol Renal Physiol. 2002 Aug;283(2):F294-301. doi: 10.1152/ajprenal.00347.2001. Am J Physiol Renal Physiol. 2002. PMID: 12110513
-
Importance of cyclooxygenase-1/prostacyclin in modulating gastric mucosal integrity under stress conditions.J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:3-10. doi: 10.1111/jgh.12767. J Gastroenterol Hepatol. 2014. PMID: 25521725
-
Interactions between COX-2 and the renin-angiotensin system in the kidney.Acta Physiol Scand. 2003 Apr;177(4):423-7. doi: 10.1046/j.1365-201X.2003.01101.x. Acta Physiol Scand. 2003. PMID: 12648159 Review.
-
New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.Urol Clin North Am. 1975 Jun;2(2):237-57. Urol Clin North Am. 1975. PMID: 1098253 Review.
Cited by
-
Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice.Biomed Res Int. 2018 Oct 2;2018:7902081. doi: 10.1155/2018/7902081. eCollection 2018. Biomed Res Int. 2018. PMID: 30386795 Free PMC article. Review.
-
Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.Biochem J. 2005 Nov 1;391(Pt 3):561-6. doi: 10.1042/BJ20050451. Biochem J. 2005. PMID: 16008526 Free PMC article.
-
Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.Br J Pharmacol. 2018 Sep;175(17):3453-3469. doi: 10.1111/bph.14386. Epub 2018 Jul 22. Br J Pharmacol. 2018. PMID: 29859010 Free PMC article.
-
Mental and Body Health: The Association between Psychological Factors, Overweight, and Blood Pressure in Young Adults.J Clin Med. 2022 Apr 2;11(7):1999. doi: 10.3390/jcm11071999. J Clin Med. 2022. PMID: 35407607 Free PMC article.
-
Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4.Heart Vessels. 2023 Apr;38(4):606-613. doi: 10.1007/s00380-022-02219-4. Epub 2022 Dec 16. Heart Vessels. 2023. PMID: 36522555 Free PMC article.
References
-
- Pickering, T.G., and Laragh, J.H. 1991. Renovascular hypertension. In The kidney. B.M. Brenner and F.C. Rector, Jr., editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 1940–1967.
-
- Hartner A, Goppelt-Struebe M, Hilgers KF. Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension. 1998;31:201–205. - PubMed
-
- Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am. J. Physiol. 2001;281:F1–F11. - PubMed
-
- Imanishi M, Tsuji T, Nakamura S, Takamiya M. Prostaglandin I2/E2 ratios in unilateral renovascular hypertension of different severities. Hypertension. 2001;38:23–29. - PubMed
-
- Jackson EK, Gerkens JF, Brash AR, Branch RA. Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog. J. Pharmacol. Exp. Ther. 1982;222:410–413. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials